MOB1B and diffuse large B-cell lymphoma: Our study demonstrated that KIAA1429 might facilitate DLBCL progression by inhibiting CHST11 expression and attenuating the activation of Hippo–YAP signaling caused by the interaction of CHST11 with MOB1B.